drugset / Trial / NCT01477632
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
RandomizedCrossoverOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to determine the extent of bioavailability of two low dose estradiol/norethisterone acetate (NETA) preparations with a marketed estradiol/norethisterone acetate (NETA) preparation.
Timeline
- Start
- 2005-03
- Primary completion
- 2005-06
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.5 mg | Oral |
| Subject | Estradiol | Other / unclassified | 1 mg | Oral |
| Subject | Norethindrone | Unknown | 0.1 mg | Oral |
| Subject | Norethindrone | Unknown | 0.25 mg | Oral |
| Subject | Norethindrone | Unknown | 0.5 mg | Oral |
Indications
No indication recorded.